Autopsy report · NCT05227456

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

“Difficulty in Recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Saskatchewan Health Authority - Regina Area

Sponsor type

University, hospital or other

Conditions

Abnormal Uterine Bleeding; Dysmenorrhea

Interventions

Etonogestrel 68mg implant; Etonogestrel 68mg implant

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (98% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (97% match in meaning)
• Intestinal Dysbiosis During Obstructive Sleep Apnea Syndrome
  “recruitment difficulty” (97% match in meaning)
• Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain
  “difficulty of recruitment” (97% match in meaning)
• Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans
  “Difficulties with recruitment” (97% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.